Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Quintiles
 More »

  • "A New Model in Clinical Development": Merck Serono Teams Up...
    Merck Serono, a division of Merck, and contract research company Quintiles have entered a ... development programs, with Quintiles directing clinical trial planning and execution. ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    the deals listed below, for example, Agilent Technologies (which acquired Danish-owned Dako last year) has earlier collaboration agreements with AstraZeneca, Quintiles, and Roche. ...
    5-9-2013
  • Biosimilars: 10 Drugs to Watch
    ... On April 5, Lonza issues statement denying news reports that it will end its biosimilar joint venture with Teva 4 Samsung Biologics: Venture between Samsung and Quintiles halts ...
    4-22-2013
  • Personalized Medicine: Health Economic Aspects
    According to the recent Quintiles report "biopharma and managed care executives are optimistic that personalised medicine will improve efficacy, safety and public health". 1 ...
    4-2-2013
  • Electronics Giants Set Sights on Biotech
    ... Samsung and Sony representatives did not respond to e-mailed questions from GEN. Samsung joined with Quintiles to form Samsung Biologics in April 2011. A month later, the unit ...
    4-1-2013
  • Replicating Human Organ Biology In Vitro
    ... has partnered with Expression Analysis, a Quintiles company, to develop the first comprehensive human response database for evaluating the vascular pharmacology of drug compounds. ...
    2-15-2013
  • Top 10 VC & Biopharma Equity Deals of 2012
    ... and two undisclosed investors Purpose: Launch global Phase III program with partner Quintiles in Q1 2013 for lead product candidate ITCA 650 (continuous subcutaneous delivery of ...
    2-8-2013
  • Necessary Liaisons: CROs Gain Clout & Responsibility
    reach $30 billion in 2015. A handful of giants-Quintiles, Covance, PPD, Parexel, ICON, etc.-dominate the landscape, but many more small and medium-size CROs also serve the market. ...
    1-1-2013
  • Boosting Clinical Trial Participation
    Clinical Research Advantage (CRA) entered into a strategic agreement with Quintiles to ... Jones, svp, integrated site services, Quintiles. "Many chronic conditions such as ...
    11-26-2012
  • Looking for jobs at DDT
    The Biotech companies that sent representatives included Archemix, Alkermes, Alnylam, Biogen Idec, Genzyme, Genentech, Millipore and Lonza Biologics. Quintiles Transnational, a ...
    8-14-2012
  • Quintiles Snaps Up EA
    Quintiles said it acquired Expression Analysis (EA), a provider of genomics testing and ... addition of EA's Genomic Know-How® to Quintiles is another step forward in our efforts ...
    8-13-2012
  • People in the News
    Tom Pike Tom Pike is now CEO of Quintiles. Pike worked for 22 years at Accenture. There, he led the North America health andp roducts business areas, was the global COO for ...
    6-1-2012
  • CRO Capabilities Expand to Suit Client Needs
    ... On the other hand, Quintiles is a clinical research organization that partners with ... In the second phase of growth in this industry, companies like Parexel, Quintiles, and ...
    5-15-2012
  • Telling the Story of Biotechnology
    Lilly & Co., Genentech, Genzyme, Merck, Millennium, Pfizer, Quintiles, and Thermo Fisher. ... Dennis Gillings, chairman and CEO of Quintiles; John Lechleiter, chairman and CEO of ...
    5-1-2012
  • Quintiles, Russian Government Fund to Expand Clinical Development...
    Quintiles is teaming up with the investment organization Russian Venture Company (RVC) ... explains Egor Beketov, RVC Biofund CEO. Quintiles has been carrying out clinical trials in ...
    2-24-2012
  • More »

    Journal Articles

  • Prevalence and Determinants of Hyperuricemia in Middle-Aged,...
    Raquel Villegas, Yong-Bing Xiang, Qiuyin Cai, Sergio Fazio, MacRae Linton, Honglan Li, Tom Elasy, Wei Zheng, Xiao Ou Shu
    Metabolic Syndrome and Related Disorders
    Physical activity was inversely related to the prevalence of hyperuricemia. The odds ratios for hyperuricemia for quintiles of nonoccupational physical activity were 1.00, 0.80, ...
  • Glycosylated Hemoglobin and Prevalent Metabolic Syndrome in Nondiabeti...
    Vikas Veeranna, Krithi Ramesh, Sandip K. Zalawadiya, Ashutosh Niraj, Jyotiranjan Pradhan, Sony Jacob, Luis Afonso
    Metabolic Syndrome and Related Disorders
    Methods: A total of 9,022 nondiabetic participants of National Health and Nutrition Examination Surveys 1999-2008 (age, 47.5±18.3 years, 51% females) were divided into quintiles ...
  • Regional Variations in Palliative Care: Do Cardiologists Follow...
    Dan D. Matlock, Pamela N. Peterson, Brenda E. Sirovich, David E. Wennberg, Patricia M. Gallagher, F. Lee Lucas
    Journal of Palliative Medicine
    use in the last 6 months of life were less likely to have discussions about palliative care (23% versus 32% for comparisons between the highest and lowest quintiles, p?=?0.04). ...
  • An Updated Report on Complications Following Robotic Prostatectomy...
    Michael Maddox, Michael S Lasser, Joseph Renzulli, Gyan Pareek
    Journal of Endourologyand Part B, Videourology
    quintiles (p=0.17). The first quintile was found to have a significantly higher major complication rate than that of the second quintile (p=0.05). The subsequent quintiles ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll